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Abstract 
The present study has investigated the modulating effect of carnosic acid on the expression pattern of cell 
proliferative  (proliferating cell nuclear antigen (PCNA) cyclin D1 and a transcription factor c-fos), apoptotic (p53, Bcl-2, 
Bax caspase -3 and 9), inflammatory (Nuclear factor kappa B (NFκB) and cyclooxygenase-2 (COX- 2) and angiogenic 
(vascular endothelial growth factor (VEGF) markers during 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster 
buccal pouch carcinogenesis. Oral tumors were developed in the hamsters buccal pouches by painting with 0.5% DMBA in 
liquid paraffin three times a week for 14 weeks. Hundred per cent tumour formation (well-differentiated squamous cell 
carcinoma) accompanied by deregulation in the above mentioned molecular markers was noticed in hamsters treated with 
DMBA alone (tumour bearing hamsters). Oral administration of carnosic acid at dose of 10mg/kg bw to hamsters treated 
with DMBA not only completely prevented the tumour formation, but also corrected the abnormalities in the expression 
pattern of molecular markers. The present study suggests that carnosic acid might have inhibited the tumour formation by 
exerting anti-cell-proliferative, anti-inflammatory, anti-angiogenic and apoptotic potential during DMBA-induced hamster 
buccal pouch carcinogenesis. 
   Key words:  oral cancer, apoptosis, angiogenesis, inflammation, cell proliferation.  
   Abbreviations: COX-2 – cyclooxygenase-2, DMBA-7,12-dimethylbenz(a)anthracene, NFκB – Nuclear factor kappa B,      
PCNA –     Proliferating cell nuclear antigen, VEGF – Vascular endothelial growth factor. 
 
  Introduction 
  Oral cancer, the fifth most common malignancy worldwide, causes significant morbidity and mortality worldwide 
with substantial economic, physiological and psychological impacts. Globally, around 5 million oral cancers are 
diagnosed annually and of these two third are reported from developing countries including India (Seki et al., 2011). 
While oral cancer accounts for 3-4% of all cancers in USA, this form of cancer comprises about 40-50% of all cancers in 
India. Tobacco and alcohol consumption, in various forms, are strongly attributed to the pathogenesis of oral cancer (Saba 
et al., 2011). Despite significant improvements have been made for oral cancer treatment with surgical therapy, radiation 
therapy and chemotherapy, the overall five year survival rate of oral cancer patients remains at about 50% and has not 
significantly improved for the last three to four decades (Schwartz, 2000). Oral squamous cell carcinoma (SCC) often has 
a poor prognosis, owing to local tumour invasion and frequent lymph node metastasis.  
  Oral carcinogenesis is a multistep process and requires accumulation of carcinogen-induced genetic changes 
throughout the carcinogen treated tissues (Neville and Day, 2002). 7,12-dimethylbenz(a)anthracene (DMBA) induced oral 
carcinogenesis in golden Syrian hamsters is an accepted and well recognized experimental model for studying 
biochemical, histopathological and molecular alterations occurring in oral carcinogenesis. DMBA induced molecular 
changes in the buccal mucosa of golden Syrian hamsters closely mimics or resembles to that of human oral tumour 
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(Balasenthil et al., 2000; Manoharan et al., 2010a). Investigation of biomarkers’ presence, quantity and expression pattern 
would help to correlate to the probability of malignant transformation of a cell or tissue. Evaluation of biomarkers would 
also help to identify patients who require more aggressive management (Agra et al., 2008). Immunohistochemical analysis 
of biomarkers could help to establish a direct association between the morphology and the biomarkers, which can aid in 
determining their functional relevance (Garcıa-Montesinos-Perea et al., 2005). Extensive studies suggested that neoplastic 
transformation has been associated with abnormalities in oncogenes and tumour suppressor genes that control cell cycle 
(Garg et al., 2008; Levine and Puzio-Kuter, 2010). Molecular markers of cell proliferation, apoptosis, angiogenesis and 
inflammation have been studied as potential tools to predict the prognosis of patients with oral squamous cell carcinoma 
(Letchoumy et al., 2007; Lindstrom et al., 2007). 
   In recent years, terpenoids received much attention due to their diverse pharmacological properties including 
anticancer potential. Carnosic acid, a phenolic diterpene, is abundant in Rosmarinus officinalis (rosemary). Carnosic acid 
possesses diverse biological and pharmacological activities, which include anti-inflammatory, antigenotoxic, antioxidant 
and anticarcinogenic effects (Manoharan et al., 2010b; Tsai et al., 2011). Offord et al. (2002) reported the photoprotective 
potential of carnosic acid in UVA–irradiated human skin fibroblasts. Previous studies from our laboratory demonstrated 
the chemopreventive potential of carnosic acid by analysing the status of biochemical markers that are related to 
carcinogenesis in DMBA induced  hamster buccal pouch carcinogenesis (Manoharan et al.,2010a; Manoharan et al., 
2010b; Manoharan et al., 2011). To provide further scientific validity to the chemopreventive potential of carnosic acid, 
the present study has investigated its modulating effect on the expression pattern of cell proliferative (PCNA, cyclin D1 
and c-fos), apoptotic (p53, Bcl-2, Bax caspase -3 and 9), inflammatory (NFκB and COX-2) and angiogenic (VEGF) 
markers during 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch carcinogenesis.    
 
 
Materials and Methods 
Animals 
    
   Male golden Syrian hamsters, aged 8–10 weeks, weighing 80–120 g, were purchased from the National Institute 
of Nutrition, Hyderabad, India and were maintained in the Central Animal House, Rajah Muthaiah Medical College and 
Hospital, Annamalai University. The animals were housed five in a polypropylene cage and provided with a standard 
pellet diet (Agro Corporation Pvt. Ltd., Bangalore, India) and water ad libitum. The animals were maintained under 
controlled conditions of temperature (27±2◦C) and humidity (55±5%) with a 12 h light/dark cycle. 
 
Chemicals 
 
           7,12-dimethylbenz(a)anthracene and carnosic acid were obtained from Sigma–Aldrich Chemical Pvt. Ltd., 
Bangalore, India. PCNA, Bcl-2, Bax, VEGF and p53 primary antibodies were purchased from Dako, Carprinteria, CA, 
USA. Power BlockTM reagent and secondary antibody conjugated with horseradish peroxidase were purchased from 
BioGenex, San Ramon, CA, USA. c-fos ELISA kit was purchased from Uscn Life Science Inc. Wuhan, China. The 
caspase-3 and -9 colorimetric assay kits were purchased from Biovision, Mountain View, CA, USA. COX activity assay 
kit was purchased from Cayman Chemical Co., USA. Trizol reagent was purchased from Invitrogen, CA, USA. cDNA 
reverse transcriptase kit and SYBR green fluorophore  assay reagents were purchased from Applied Biosystems, Foster 
City, CA. Oligo nucleotide primers were purchased from Bangalore Genei.  
 
 
Experimental design 
 
           The institutional animal ethics committee (Register number 160/1999/CPCSEA), Annamalai University, 
Annamalainagar, India, approved the experimental design. The animals were maintained as per the principles and 
guidelines of the ethical committee for animal care of Annamalai University in accordance with Indian National Law on 
animal care and use.  A total number of 40 hamsters were randomized into four groups of ten animals in each. Group I 
animals served as control and were painted with liquid paraffin alone three times  a week for 14 weeks on their left buccal 
pouches. Groups II and III animals were painted with 0.5% DMBA in liquid paraffin three times a week for 14 weeks on 
their left buccal pouches. Group III animals were orally given carnosic acid at a dose of 10mg/kg body weight /day, 
starting one week before exposure to the carcinogen and continued on days alternate to DMBA painting, until the end of 
the experiment. Group IV animals received oral administration of carnosic acid10mg/kg body weight/day alone 
throughout the experimental period. The experiment was terminated at the end of 16 weeks and all animals were sacrificed 
by cervical dislocation.  
 
Immunohistochemical staining             
 
           Paraffin embedded tissue sections were dewaxed and rehydrated through grade ethanol to distilled water. 
Endogenous peroxidase was blocked by incubation with 3% H2O2 in methanol for 10 minutes. The antigen retrieval was 
achieved by microwave in citrate buffer solution (2.1 g citric acid/L D.H2O; 0.37g EDTA/L D.H2O; 0.2g Trypsin)  (pH 
6.0) for 10 minutes, followed by washing step with Tris-buffered saline (8g Nacl; 0.605g Tris) (pH 7.6). The tissue section  
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               Table. 2: Incidence of oral neoplasm and histopathological changes in control and experimental animals in each group (n=10) 
 
 
                   
                   
     Values are expressed as mean± SD for 10 hamsters in each group Tumour volume was measured using the 
formula, v = (4/3)π [D1/2][D2/2][D3/2] where D1, D2 and D3 are the three diameters (mm) of the tumour.  Tumour burden was calculated by 
multiplying tumour volume and the number of tumours/animal. +++ - Severe; + -  Mild. 
 
Parameter 
Group I    
Control 
Group II 
DMBA alone 
Group III 
DMBA + Carnosic acid 
Group VI 
Carnosic acid alone 
Tumour incidence (oral squamous cell 
carcinoma) 
0 100% 0 0 
Total number of tumours/animals 0 26/10 0 0 
Tumour volume (mm3)/ animals 0 239.98  11.09  0 0 
Tumour burden (mm3)/ animals 0 623.94  48.20  0 0 
Hyperkeratosis   Absent                              +++                     +           Absent 
Hyperplasia    Absent                              +++                     +           Absent 
Dysplasia    Absent                             +++                     +           Absent 
Squamous cell carcinoma                Absent                 Well                       
 differentiated     
             Absent            Absent 
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Table. 3. The score of positively stained cells of PCNA, p53, Bcl-2, Bax and VEGF in control and experimental hamsters in each group 
 
PCNA P53 Bcl2 Bax VEGF 
Groups / Markers 
0 1+ 2+ 3+ 0 1+ 2+ 3+ 0 1+ 2+ 3+ 0 1+ 2+ 3+ 0 1+ 2+ 3+ 
Control 10 0 0 0 10 0 0 0 8 2 0 0 1 4 3 2 10 0 0 0 
DMBA 
0 1 2 7 0 1 3 6 0 1 2 7 7 2 1 0 0 2 3 5 
DMBA + carnosic acid 
0 6 3 1 1 5 3 1 3 5 2 0 3 3 4 0 7 2 1 0 
Carnosic acid alone 
 
10 
 
0 
 
0 
 
0 
 
10 
 
0 
 
0 
 
0 7 3 0 0 2 3 3 2 10 0 0 0 
 
 
Values are given as number of hamsters (n = 10). The percentage positive cells were scored as: 3+ = strong staining, more than 50% of cells were stained, 2+ = moderate staining, between 20 and 50% 
of cells were stained 1+ = week staining, between 1 and 20% of cells were stained,   0 = negative, less than 1% of cell staining. 
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was then incubated with power BlockTM reagent (BioGenex, San Ramon, CA, USA), universal proteinaceous blocking 
reagent, for 15 minutes at room temperature to block non-specific binding sites. The tissue sections were then incubated 
with the respective primary antibody (p53, Bcl-2, Bax, PCNA and VEGF - Dako, Carprinteria, CA, USA) overnight at 
4°C. The bound primary antibody was detected by incubation with the secondary antibody conjugated with horseradish 
peroxidase (BioGenex, San Ramon, CA, USA) for 30 minutes at room temperature. After rinsing with Tris-buffered 
saline, the antigen-antibody complex was detected using 3,3´-diamminobenzidine, the substrate of horseradish peroxidase. 
When acceptable color intensity was reached, the slides were washed, counter stained with hematoxylin and covered with 
a mounting medium. Each slide was microscopically analyzed and enumerated the percentage of the positively stained 
cells semi-quantitatively. The percentage of positive cells was scored according to the method of Nakagawa et al. (1994) 
as follows: 3+ = strong staining, more than 50% of cells were stained; 2+ = moderate staining, between 20 and 50% of 
cells were stained; 1+ = week staining, between 1 and 20% of cells were stained; 0 = negative, less than 1% of cell 
staining. 
 
Estimation of caspase- 3 and 9, COX-2 and c-fos activities by enzyme linked immunosorbent assay [ELISA] 
 
           The activities of c-fos, COX-2, caspase-3 and -9 were assayed in the buccal mucosa using ELISA kit for c-fos, 
Cayman’s COX activity assay kit for COX-2, colorimetric assay kits for caspase-3 and caspase-9 according to the 
manufacturer’s instructions respectively. In c-fos assay, the buccal mucosa tissues were homogenized in 1X PBS and the 
supernatant obtained was added to the microtiter plate wells precoated with biotin-conjugated antibody preparation specific 
to c-fos.  Then, Avidin conjugated Horseradish peroxidase (HRP) followed by TMB substrate was added to each well.  The 
enzyme – substrate reaction was terminated by the addition of a sulphuric acid and the color change was measured at 450 nm 
in a microtiter plate reader.  The peroxidase activity of COX-2 activity was assayed colorimetrically by monitoring the 
appearance of oxidized N, N, N’, N’ – tetramethyl– P - phenylenediamine (TMPD) at 590 nm. The caspase-3 and -9 assays 
are based on spectrophotometric detection of the chromophore p-nitroanilide (pNA) after cleavage from the labeled substrate 
DEVD – pNA and LEHD–pNA respectively at 405nm in a microtiter plate reader.   
 
Expression of NFκB and Cyclin D1 using Real Time PCR 
 
           Total RNA from the buccal mucosa was extracted with Trizol reagent. The RNA integrity and concentration was 
determined by electrophoresis on agarose gel and nanodrop analysis at 260 nm. Isolated total RNA (1µg) was reverse 
transcribed to cDNA with random primers from the High cDNA Reverse Transcriptase Kit. cDNA was amplified in 
duplicates using a thermal cycler (9700 HT RT – PCR, Applied Biosystem, UK) for the expression of NFκB, Cyclin D1 and 
β-actin with SYBR green fluorophore following the manufacturer’s recommended amplification procedure. List of primers 
used for Real-time PCR analysis was given in Table 1. The relative quantification of target gene expression was determined 
using the comparative CT method. The ΔCt was calculated as the difference between the average Ct values of the 
endogenous control (β-actin) from the average Ct value of test gene. The ΔΔCt was determined by subtracting the ΔCt of the 
control from the ΔCt of the test sample. Relative expression of the target gene was calculated by the formula, 2-ΔΔCt, which 
was the amount of gene product, normalised to the endogenous control and relative to the control sample. 
 
Statistical analysis 
 
           The data is expressed as mean ± standard deviation (S.D.) Statistical comparisons were performed by one-way 
analysis of variance followed by Duncan’s Multiple Range Test. The results were considered statistically significant if the P 
values were less than 0.05. 
 
 
 
Results 
 
           The tumor occurence, tumor volume, tumor burden and histological changes in the buccal mucosa of control and 
experimental animals are shown in Table 2. We have observed 100% tumor formation with mean tumor volume 
(239.98mm3) and tumor burden (623.94mm3) in DMBA alone-painted animals (Group II). The tumor was histopathologically 
confirmed as well differentiated squamous cell carcinoma. Oral administration of carnosic acid at a dose of 10mg/kg body 
weight completely prevented the tumor occurence and reduced the severities of hyperplasia, dysplasia and hyperkeratosis in 
DMBA-painted hamsters (Group III). No tumor was observed in control animals painted with liquid paraffin alone (Group I) 
as well as carnosic acid alone administered animals (Group IV). 
           The immunoexpression pattern of cell proliferative (PCNA), apoptotic (p53, Bcl-2 and Bax) and angiogenic (VEGF) 
markers and the score of positively stained cells in control and experimental hamsters in each group are depicted in figure 1 
(A-E) and Table 3 respectively. Over expression of all these markers except Bax was noticed in hamsters treated with DMBA 
alone. Oral administration of carnosic acid at a dose of 10mg/kg bw to hamsters treated with DMBA significantly restored 
the expression of above markers. Hamsters treated with carnosic acid alone revealed expression similar to that of control 
hamsters. 
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Figure. 1: (A-E). Immunoexpression pattern of PCNA, p53, Bcl-2, Bax and VEGF proteins observed in the buccal mucosa 
of control and experimental hamsters in each group (40X).  (A) PCNA: A and D - Control and carnosic acid alone 
(expression not detectable),B - DMBA alone (over expressed),C - DMBA + carnosic acid (down regulated). (B) 
P53: E and H - Control and carnosic acid alone (expression not detectable); F - DMBA alone (over expression); G - 
DMBA + carnosic acid (down regulated). (C) Bcl-2: I and L - Control and carnosic acid alone (expression not 
detectable); J - DMBA alone (over expression); K - DMBA + carnosic acid (down regulated). (D) Bax: M and P - 
Control and carnosic acid alone (nuclear expression positive), N - DMBA alone (nuclear expression negative), O - 
DMBA + carnosic acid (nuclear and cytoplasmic expression positive). (E) VEGF: Q and T - Control and carnosic 
acid alone (expression not detectable), R - DMBA alone (overexpressed), S - DMBA + carnosic acid (down 
regulated). 
 
 
 
Buccal mucosa caspase-3 and 9, COX-2 and c-fos status of control and experimental hamsters in each group is shown in 
figure 2. The activities of caspase-3 and -9 were significantly decreased whereas COX-2 and c-fos were increased in 
hamsters treated with DMBA alone. Oral administration of carnosic acid to hamsters treated with DMBA brought back the 
status of above markers to near normal range. No significant difference was noticed in the status of above markers in control 
hamsters and hamsters treated with carnosic acid alone. 
           The NFκB and Cyclin D1 mRNA expression pattern of control and experimental hamsters in each group is depicted in 
figure 3. The expression of NFκB and Cyclin D1 were significantly higher in hamsters treated with DMBA alone as 
compared to control hamsters. Oral administration of carnosic acid to hamsters treated with DMBA suppressed the 
expression of Cyclin D1 and NFκB. Similar expression pattern of Cyclin D1 and NFκB was observed in control hamsters and 
hamsters treated with carnosic acid alone. 
 
 
 
Discussion        
 
    Carnosic acid, a phenolic diterpene, exhibited antitumor properties in both in vivo and in vitro conditions 
(Manoharan et al., 2010b; Tsai et al., 2011). Manoharan et al. (2010b) reported that carnosic acid exhibited potent 
chemopreventive efficacy during DMBA-induced oral carcinogenesis. They concluded that the chemopreventive potential of 
carnosic acid is probably due to its antioxidant potential and modulating effect on phase I and II detoxification enzymes  
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Figure. 2:  Buccal mucosa Caspase-3 and -9, COX-2 and c-fos activity in control and experimental hamsters in each group. 
Values are expressed as mean ± SD for 10 hamsters in each group. Values that do not share a common superscript 
letter between groups differ significantly at p < 0.05.  (Analysis of variance followed by DMRT). 
 
 
 
 
 
 
                               Table. 1: List of Primers Used for Real-time PCR Analysis 
 
Genes Primers Sequences 
NFκB forward 
reverse 
5′-ATGGACGATCTGTTTCCCCT-3′ 
5′- CGGTTTACTCGGCAGATCTT-3′ 
Cyclin D1 forward 
reverse 
5'-CGGAGGACAACAAACAGATC-3';  
5'-GGGTGTGCAAGCCAGGTCCA-3' 
β-actin forward 
reverse 
5'-AACCGCGAGAAGATGACCCAGATCATGTTT-3’  
5'-AGCAGCCGTGGCCATC TCTTGCTCGAAGTC-3' 
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Figure. 3:  Fold increase in the mRNA expression pattern for NF-κB and Cyclin D1 in hamsters treated with DMBA alone, 
DMBA + carnosic acid and carnosic acid alone. Values are expressed as mean ± SD for 10 hamsters in each group. 
Values that do not share a common superscript letter in the same column differ significantly at p < 0.05. (Analysis 
of variance followed by DMRT). 
 
 
 
 
during DMBA-induced oral carcinogenesis. To further confirm the chemopreventive potential of carnosic acid,  the present 
study focuses the modulating effect of carnosic acid on apoptotic, cell proliferative, inflammatory and angiogenic markers 
during DMBA-induced oral carcinogenesis. Deregulation in the above mentioned markers could result in neoplastic 
transformation.  
           In the present study, we noticed up-regulation of cell proliferation markers (PCNA, cyclin D1 and c-fos) during 
DMBA-induced hamster buccal pouch carcinogenesis. PCNA, a nuclear non-histone antigen, play an important role in both 
DNA synthesis and DNA repair (Mallick et al., 2010). Immunohistochemical studies using anti-PCNA antibody is commonly 
employed to measure abnormal cell proliferation during carcinogenesis. Over expression of PCNA has been shown in several 
cancers including oral cancers (Cheng et al., 2007; Harish Kumar et al., 2010). Cyclin D1, one of the most important cell 
cycle regulator protein, plays pivotal role in the control of restriction point of G1 phase. Deregulation in cyclin D1 expression 
has been associated with the progression and recurrence of tumours.  It has been reported that p53 mutation preceded cyclin 
D1 amplification in carcinogenesis (Fu et al., 2004). Amplification and over expression of cyclin D1 resulted in the 
suppression of NFkB expression (Elayat et al., 2011). Over expression and amplification of cyclin D1 was reported in several 
human cancers including oral cancer (Shenoy, 2007; Holley et al., 2001). C-fos plays pivotal role in the regulation of cell 
growth and differentiation. Over expression of c-fos was reported in several cancers including cervical cancer, lung cancer, 
pancreatic carcinomas, osteosarcomas, hepatocellular carcinoma and colorectal adenoma (Pacheco et al., 2002; Petrov et al., 
1994). Over expression of c-fos was reported in 70% and 38% of the oral cancers and oral pre-cancerous lesions respectively 
(Vairaktaris et al., 2008; Zhang et al., 2011). Our results corroborate these observations. 
    In the present study, over expression of inflammatory markers (NFkB and COX-2) was noticed in the buccal 
mucosa of hamsters treated with DMBA alone. NFkB, an anti-apoptotic transcription factor and inflammatory marker, 
integrates multiple signals and regulates the expression of genes involved in the pathogenesis of cancer (Karin, 2006). 
Inactivation of NFkB inhibited abnormal cell proliferation, invasion, metastasis and angiogenesis. Over expression of NFkB 
has been reported in human and experimental oral carcinogenesis (Wang et al., 2011). Cyclooxygenase-2 (COX-2), a key 
regulatory enzyme in the synthesis of prostaglandins, was upregulated in precancerous and cancerous conditions. In recent 
years, researchers thus utilize COX-2 as a novel target for the prevention of many cancers including oral cancer (McCormick 
et al., 2010). Deregulation of COX-2 expression could lead to abnormal production of VEGF thereby contributing to 
angiogenesis in tumour tissues (Turini and Dubois, 2002). Immunohistochemical analysis revealed over expression of COX-2 
in oesophagus, stomach, breast, pancreas, lung, colon, skin, urinary bladder and prostate cancers (Mendes et al., 2009). 
Increased levels of COX-2 were shown in premalignant lesions of oral cavity (Mallery et al., 2008). A positive association 
between mutant p53 and over expression of COX-2 has been shown in oral carcinogenesis (Nishimura et al., 2004). 
    In the present study, up-regulation of p53 and bcl-2 and down-regulation of Bax was noticed in the buccal mucosa 
of hamsters treated with DMBA alone. Under normal conditions, p53 expression results in cell cycle arrest and apoptosis. 
Abnormalities in the p53 tumour suppressor gene are the most common molecular changes associated with the development 
of several cancers including oral cancer (Panjamurthy et al., 2009). p53 stimulates the up-regulation of Bax and down 
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regulation of Bcl-2 to remove the unwanted cells from the host (Merchant et al.,1996). Anti-apoptotic and pro-apoptotic 
proteins comprises the Bcl-2 family and these proteins share sequence homology within conserved regions known as Bcl-2 
homology (BH) domains. Immunohistochemical studies on normal epithelium showed Bcl-2 was restricted to the lower 
epithelial cell layers and Bax was diffused throughout the epithelium. Over expression of Bcl-2 indirectly inhibit the process 
of apoptosis and thus play a role in the onset of tumouregenesis (Kanekawa et al., 1999). Bcl-2 could favour tumour 
progression through extended cell survival (ChandraMohan et al., 2006). Bax, a 21kD protein of 192 amino acids, play 
crucial role in the process of apoptosis. Over expression of Bcl-2 and down regulation of Bax has been reported in several 
cancers including oral cancer (Baltaziak et al., 2006; De Sousa et al., 2009; Balakrishnan et al., 2010).  
    A central component of the apoptotic machinery is the family of cysteine protease called caspases. Caspases are 
expressed as inactive precursors that are activated by proteolytic processing (Ho et al., 2009). In the present study, the 
activation of caspase 3 and 9 were decreased in the buccal mucosa of hamsters treated with DMBA alone.  It has been 
reported that decreased caspase 3 expression was associated with vascular invasion, lymph node metastasis and advanced 
tumour stages in oral carcinogenesis (Ding et al., 2010). Reduced expression of caspase -3 and 9 has been reported in oral 
carcinogenesis (Letchoumy et al., 2007).  
    Angiogenesis, sprouting of new blood vessels from the pre-exiting vasculature, has been implicated not only 
under physiological conditions but also in various pathological conditions including cancer, diabetic retinopathy and 
rheumatoid arthristis. The purpose of angiogenesis in tumours is to sequester nutrients from the host for tumour cell survival 
and tumour growth (Carmeliet and Jain, 2000). Extensive studies pointed out that angiogenesis have been associated with 
tumour progression and aggressiveness in a number of malignancies, including oral cancer (Uehara et al., 2004; 
Shivamallappa et al., 2011). In the present study, we noticed over expression of VEGF in the buccal mucosa of hamsters 
treated with DMBA alone. Over expression of VEGF has been demonstrated in varying degrees of oral dysplasia and 
carcinoma (O-charoenrat et al., 2001). Deregulation of VEGF resulted in the progression of oral cancer, due to up-regulation 
of microvessel density. The VEGF serum concentration was significantly higher in patients with oral squamous cell 
carcinoma as compared to normal subjects (Seki et al., 2011). 
    Extensive studies investigated the modulating effect of carnosic acid on the expression pattern of molecular 
markers that are related to carcinogenesis. Visanji et al. (2006) reported that carnosic acid caused cell cycle arrest at G2/M 
phase in human colonic adenocarcinoma cell line. Mengoni et al. (2011) reported that carnosic acid suppressed the 
expression of COX-2 in the inflammatory skin. Tsai et al. (2011) reported that carnosic acid induced apoptosis by down 
regulating Bcl-2 expression and activating caspases -3 and 9 in human neuroblastoma IMR-32 cells. Kar et al. (2012) 
reported that carnosic acid induced apoptosis by activation of serine/threonine protein phosphatise 2A through modulation of 
Akt/IKK/NF-Κb pathway in human prostate carcinoma PC-3 cells. Carnosic acid induced apoptosis in prostate cancer DU 
145 cells by activating caspase-3 and increasing cytochrome-c releases and Bax: Bcl-2 ratio. Barni et al. (2012) reported that 
carnosic acid inhibited the proliferation and migration capacity of human colorectal cancer cells by down regulating the 
expression of COX-2. Lopez-Jimenez et al. (2011) reported the anti-angiogenic properties of carnosic acid and suggested that 
the anti-angiogenic potential of carnosic acid could be due to its apoptotic potential. Pesakhov et al. (2010) demonstrated that 
combinations of the dietary plant polyphenols, curcumin and carnosic acid, at non-cytotoxic concentrations of each agent, 
produced a synergistic antiproliferative effect and a massive apoptotic cell death in HL-60 and KG-1a human AML cells.  
In the present study, oral administration of carnosic acid at a dose of 10mg/kg bw restored the expression pattern of markers 
of cell proliferation, inflammation, apoptosis and angiogenesis in hamsters treated with DMBA. The results of the present 
study suggests that carnosic acid modulated the expression cell proliferative (PCNA, cyclin D1 and c-fos), apoptotic (p53, 
Bcl-2, caspase -3 and 9), inflammatory (NFκB and COX-2) and angiogenic (VEGF) in favour of inhibiting the abnormal cell 
proliferation occurring in DMBA induced hamster buccal pouch carcinogenesis.  
 
 
Conclusion 
  
    The present study demonstrates the modulating effect of carnosic acid on the expression pattern of cell 
proliferative (PCNA, cyclin D1 and c-fos), apoptotic (p53, Bcl-2, caspase -3 and 9), inflammatory (NFκB and COX-2) and 
angiogenic (VEGF) during DMBA-induced oral carcinogenesis. Carnosic acid might have inhibited the tumour formation by 
exerting anti-cell-proliferative, anti-inflammatory, anti-angiogenic and apoptotic potential during DMBA-induced hamster 
buccal pouch carcinogenesis. 
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